title: The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
abstract: OBJECTIVE
  The mutational status of the immunoglobulin heavy chain variable region genes (IGVH) is a strong indicator of prognosis in B-cell chronic lymphocytic leukaemia (CLL). Since the determination of the IGVH mutation status is very labor-intensive, alternative prognostically relevant markers would facilitate CLL diagnostics.
  
  
  METHODS
  Ten genes were selected from previously published gene expression profiling studies based on their differential expression in IGVH mutated versus unmutated cases of CLL, and tested with real-time quantitative polymerase chain reaction (RQ-PCR) in unpurified samples from 130 CLL patients. To ascertain potential contaminating effects by normal hematopoietic cells, the expression levels of the selected genes were determined in normal monocytes, B cells, T cells, NK cells and granulocytes.
  
  
  RESULTS
  The selected genes, i.e., ZAP70, LPL, SPG20, ADAM29, NRIP1, AKAP12, DMD, SEPT10, TPM2 and CLECSF2, showed prognostic significance. In multivariate logistic regression analysis expression levels of LPL, ZAP70, ADAM29 and SEPT10 were the most predictive for IGVH mutational status. In univariate analysis the expression of LPL was the best predictor. For survival, expression of LPL was the strongest prognostic factor. In combination with the three cytogenetic markers associated with a poor prognosis, i.e., deletions 17p13, 11q22 and trisomy 12, expression of LPL and IGVH mutational status performed equally well with regard to their predictive value for survival, both being more predictive than ZAP70.
  
  
  CONCLUSIONS
  This study demonstrates that LPL expression is a predictor for survival in CLL, and for this purpose is as good as IGVH mutational status and more reliable than ZAP70 expression when tested in unpurified CLL samples.
authors.affiliation: Department of Hematology, Erasmus MC, Rotterdam, The Netherlands. m.vantveer@erasmusmc.nl
authors.forename: Mars B
authors.initials: MB
authors.lastname: van't Veer
authors.forename: Anne M
authors.initials: AM
authors.lastname: Brooijmans
authors.forename: Anton W
authors.initials: AW
authors.lastname: Langerak
authors.forename: Brenda
authors.initials: B
authors.lastname: Verhaaf
authors.forename: Chantal S
authors.initials: CS
authors.lastname: Goudswaard
authors.forename: Wilfried J
authors.initials: WJ
authors.lastname: Graveland
authors.forename: Kirsten
authors.initials: K
authors.lastname: van Lom
authors.forename: Peter J M
authors.initials: PJ
authors.lastname: Valk
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000201:enzymology / Q000401:mortality; D008071:Lipoprotein Lipase / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011237:Predictive Value of Tests; D011379:Prognosis; D015996:Survival Rate
chemical_list: D008071:Lipoprotein Lipase